1st line treatment for chronic hepatitis B - دانلود رایگان
دانلود رایگان
دانلود رایگان لینک دانلود و خرید پایین توضیحاتدسته بندی : پاورپوینتنوع فایل : powerpoint (..ppt) ( قابل ويرايش و آماده پرينت )تعداد اسلاید : 40 اسلاید قسمتی از متن powerpoint (..ppt) : 1st line treatment for chronic hepatitis B HBV In Iran 50% vertical Transmission Universal Neonatal Vaccination from 1992, Adulthood Vaccination 2007 1.7% carrier rate 2007 HBV in Iran We have a minimum of 1,500,000 chronic HBV infected individual. >90% are HBeAg-Negative and D1 Genotype. At least 300,000 has active infection and need therapy. At least 3000 die each year of HBV related end stage liver disease Major goals of anti-HBV therapy Prevent the development of progressive disease, specifically cirrhosis and liver failure, as well as HCC development and subsequent death. To date, no RCTs of anti-HBV therapies have demonstrated a beneficial impact on overall mortality, liver-specific mortality, and development of HCC.